Lab Notes: FMC enters into a $200M bio-acquisition; Virpax going the OTC route again
July 08, 2022 at 16:14 PM EDT
Virpax is once again taking the OTC route for a new product candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|